ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 7.40
+0.10 (1.37%)
Mar 4, 2026, 4:29 PM GMT
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 34.94 million as of March 4, 2026. Its market cap has increased by 82.39% in one year.
Market Cap
34.94M
Enterprise Value
34.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
7.40
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 34.94M, a decrease of -3.25%. That is a compound annual growth rate of -0.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 34.94M | 12.10% |
| Dec 31, 2025 | 31.17M | 521.13% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4basebio | 85.13M |
| Bioventix | 80.99M |
| Hemogenyx Pharmaceuticals | 71.16M |
| Faron Pharmaceuticals Oy | 66.00M |
| hVIVO | 57.83M |
| Ondine Biomedical | 53.25M |
| Poolbeg Pharma | 31.73M |
| Arecor Therapeutics | 27.37M |